Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Mohs, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lesser, G; Kandiah, K; Libow, LS; Likourezos, A; Breuer, B; Marin, D; Mohs, R; Haroutunian, V; Neufeld, R
      Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    2. Brown, AM; Sheu, RKF; Mohs, R; Haroutunian, V; Blass, JP
      Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (antDNA)

      JOURNAL OF MOLECULAR NEUROSCIENCE
    3. Ho, L; Guo, YJ; Spielman, L; Petrescu, O; Haroutunian, V; Purohit, D; Czernik, A; Yemul, S; Aisen, PS; Mohs, R; Pasinetti, GM
      Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarraytechnique

      NEUROSCIENCE LETTERS
    4. Grundman, M; Kim, HT; Salmon, D; Storandt, M; Smith, G; Ferris, S; Mohs, R; Brandt, J; Doody, R; Welsh-Bohmer, K; Saxton, J; Saine, K; Schmitt, F; Ogrocki, P; Johnson, N; Howieson, D; Papka, M; Green, J; Gamst, A; Kukull, W; Thal, LJ
      The Alzheimer's disease centers' neuropsychological database initiative: Aresource for Alzheimer's disease prevention trials

      ALZHEIMER'S DISEASE
    5. Naslund, J; Haroutunian, V; Mohs, R; Davis, KL; Davies, P; Greengard, P; Buxbaum, JD
      Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    6. Luterman, JD; Haroutunian, V; Yemul, S; Purohit, D; Aisen, PS; Mohs, R; Pasinetti, GM
      Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia

      ARCHIVES OF NEUROLOGY
    7. Rogers, SL; Friedhoff, LT; Farlow, MR; Doody, RS; Mohs, R
      Efficacy of donepezil in Alzheimer's disease: Fact or artifact? Reply

      NEUROLOGY
    8. Clark, CM; Sheppard, L; Fillenbaum, GG; Galasko, D; Morris, JC; Koss, E; Mohs, R; Heyman, A
      Variability in annual mini-mental state examination score in patients withprobable Alzheimer disease - A clinical perspective of data from the consortium to establish a registry for Alzheimer's disease

      ARCHIVES OF NEUROLOGY
    9. Rogers, SL; Mohs, R; Doody, RS
      ARICEPT (R): a well-tolerated and clinically effective treatment for the symptoms of AD - Results from world-wide clinical trials

      ALZHEIMERS REPORTS
    10. HEYMAN A; FILLENBAUM G; WELSHBOHMER K; GEARING M; MIRRA SS; MOHS R; PETERSON B; PIEPER C
      CLINICAL AND NEUROPSYCHOLOGICAL FINDINGS IN PATIENTS WITH AUTOPSY EVIDENCE OF ALZHEIMERS-DISEASE WITH AND WITHOUT CEREBRAL INFARCTION - THECERAD EXPERIENCE

      Neurology
    11. ROGERS SL; FARLOW MR; DOODY RS; MOHS R; FRIEDHOFF LT; ALBALA B; BAUMEL B; BOOKER G; DEXTER J; FARMER M; FEIGHNER JP; FERRIS S; GORDON B; GORMAN DG; HANNA G; HARRELL LE; HUBBARD R; KENNEDY J; MCCARTHY J; SCHARRE DW; SCHAERF F; SCHNEIDER L; SELTZER B; SIEGAL A; STARK SR; STRAUSS A; WALSHE TM
      A 24-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DONEPEZIL IN PATIENTS WITH ALZHEIMERS-DISEASE

      Neurology
    12. PUROHIT DP; PERL DP; HAROUTUNIAN V; KAPUSTIN A; MARIN D; MOHS R
      DIFFUSE PLAQUE-FORMATION IN THE CEREBRAL-CORTEX - NEUROPATHOLOGIC OBSERVATIONS AND CORRELATION WITH COGNITIVE STATUS IN A LARGE AUTOPSY-BASED SERIES

      Journal of neuropathology and experimental neurology
    13. SHEU KFR; BROWN AM; HAROUTUNIAN V; RELKIN N; MOHS R; BLASS JP
      PERSISTENCE OF APOE4 GENE AS A RISK FACTOR FOR ALZHEIMERS-DISEASE IN OLD POPULATION WITH A LOCUS IN DLST GENE

      Journal of neurochemistry
    14. BROWN AM; SHEU KFR; HAROUTUNIAN V; MOHS R; BLASS JP
      ABNORMALITIES OF MITOCHONDRIAL COI GENE IN ALZHEIMERS-DISEASE

      Journal of neurochemistry
    15. GAUTHIER S; BODICK N; ERZIGKEIT E; FELDMAN H; GELDMACHER DS; HUFF J; MOHS R; ORGOGOZO JM; ROGERS S
      ACTIVITIES OF DAILY LIVING AS AN OUTCOME MEASURE IN CLINICAL-TRIALS OF DEMENTIA DRUGS - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUPON HARMONIZATION OF DEMENTIA DRUG GUIDELINES

      Alzheimer disease and associated disorders
    16. FERRIS SH; LUCCA U; MOHS R; DUBOIS B; WESNES K; ERZIGKEIT H; GELDMACHER D; BODICK N
      OBJECTIVE PSYCHOMETRIC TESTS IN CLINICAL-TRIALS OF DEMENTIA DRUGS - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OFDEMENTIA DRUG GUIDELINES

      Alzheimer disease and associated disorders
    17. THAL LJ; CARTA A; DOODY R; LEBER P; MOHS R; SCHNEIDER L; SHIMOHAMA S; SILBER C
      PREVENTION PROTOCOLS FOR ALZHEIMER-DISEASE - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES

      Alzheimer disease and associated disorders
    18. FERRIS SH; MACKELL JA; MOHS R; SCHNEIDER LS; GALASKO D; WHITEHOUSE PJ; SCHMITT FA; SANO M; THOMAS RG; ERNESTO C; GRUNDMAN M; SCHAFER K; THAL LJ
      A MULTICENTER EVALUATION OF NEW TREATMENT EFFICACY INSTRUMENTS FOR ALZHEIMERS-DISEASE CLINICAL-TRIALS - OVERVIEW AND GENERAL RESULTS

      Alzheimer disease and associated disorders
    19. MACKELL JA; FERRIS SH; MOHS R; SCHNEIDER L; GALASKO D; WHITEHOUSE P; SCHMITT F; SANO M; THAL LJ
      MULTICENTER EVALUATION OF NEW INSTRUMENTS FOR ALZHEIMERS-DISEASE CLINICAL-TRIALS - SUMMARY OF RESULTS

      Alzheimer disease and associated disorders
    20. ALTSTIEL LD; GREENBERG DA; MARIN D; LANTZ M; MOHS R
      APOLIPOPROTEIN-E GENOTYPE AND COGNITION IN THE VERY OLD

      Lancet
    21. ROGERS SL; DOODY R; MOHS R; FRIEDHOFF LT
      E2020 PRODUCES BOTH CLINICAL GLOBAL AND COGNITIVE TEST IMPROVEMENT INPATIENTS WITH MILD TO MODERATELY SEVERE ALZHEIMERS-DISEASE - RESULTS OF A 30 WEEK PHASE-III TRIAL

      Neurology
    22. KOSS E; EDLAND S; FILLENBAUM G; MOHS R; CLARK C; GALASKO D; MORRIS JC
      CLINICAL AND NEUROPSYCHOLOGICAL DIFFERENCES BETWEEN PATIENTS WITH EARLIER AND LATER ONSET OF ALZHEIMERS-DISEASE - A CERAD ANALYSIS .12.

      Neurology
    23. LOMBARDI J; HARVEY PD; LEIBMAN M; PARRELLA M; WHITE L; POWCHIK P; MOHS R; DAVIDSON M; DAVIS K
      AGE-RELATED-CHANGES IN FORMAL THOUGHT-DISORDER IN CHRONIC-SCHIZOPHRENIC PATIENTS

      Biological psychiatry
    24. BERGMAN A; SILVERMAN J; SMITH C; SIEVER L; MOHS R; DAVIS K
      FACTOR STRUCTURE OF SCHIZOTYPY IN RELATIVES OF SCHIZOPHRENIA-PATIENTS

      Biological psychiatry
    25. HARVEY PD; LOMBARDI J; WHITE L; PARRELLA M; POWCHIK P; MOHS R; DAVIDSON M
      DETERMINANTS OF CATEGORY AND PHONEMIC FLUENCY DEFICITS IN CHRONIC-SCHIZOPHRENICS

      Biological psychiatry
    26. KANDIAH K; EPSTEIN D; NEUFELD R; BREUER B; MOHS R; MARIN D; RODSTEIN M; LIBOW LS
      SIGNIFICANCE OF THE APOLIPOPROTEIN-E GENOTYPES IN ALZHEIMERS-DISEASE,VASCULAR DEMENTIA AND CORONARY-ARTERY DISEASE

      Journal of the American Geriatrics Society
    27. SIEGEL B; SHIBABUDDIN L; MOHS R; BUCHSBAUM M
      GENDER DIFFERENCES IN REGIONAL BRAIN GLUCOSE-METABOLISM IN ALZHEIMERS-DISEASE AND NORMAL AGING

      The American journal of geriatric psychiatry
    28. ALTSTIEL LD; LAWLOR B; MOHS R; SCHMEIDLER J; DALTON A; MEHTA P; DAVIS K
      ELEVATED ALPHA(1)-ANTICHYMOTRYPSIN SERUM LEVELS IN A SUBSET OF NONDEMENTED FIRST-DEGREE RELATIVES OF ALZHEIMERS-DISEASE PATIENTS

      Dementia
    29. SIEVER LJ; TRESTMAN RL; SIEGEL BV; LOSONCZY M; MITROPOULOU V; SILVERMAN J; KEEFE R; MOHS R; BUCHSBAUM M; DAVIS KL
      NEUROIMAGING, NEUROBIOLOGICAL, AND NEUROPSYCHOLOGICAL ABNORMALITIES IN SPD IMPLICATIONS FOR A MODEL OF THE SCHIZOPHRENIA SPECTRUM

      Schizophrenia research
    30. MCDANIEL KD; EDLAND SD; HEYMAN A; HARRELL L; HENDERSON V; WIEDERHOLT WC; KARP H; EVANS DA; BENNETT DA; CLARK DB; BRANDT J; GROWDON J; FOSTER NL; MORTIMER J; MORRIS J; BLASS J; MAYEUX R; MOHS R; FERRIS S; TARIOT P; EARL NL; FRIEDLAND R; CLARK C; DEKOSKY ST; DOODY R; WEINER M; LARSON E; RASKIND M; BERG L; VANBELLE G; FILLENBAUM G
      RELATIONSHIP BETWEEN LEVEL OF INSIGHT AND SEVERITY OF DEMENTIA IN ALZHEIMER-DISEASE

      Alzheimer disease and associated disorders
    31. SIEVER LJ; ROTTER M; LOSONCZY M; GUO SL; MITROPOULOU V; TRESTMAN R; APTER S; ZEMISHLANY Z; SILVERMAN J; HORVATH TB; DAVIDSON M; MOHS R; DAVIS KL
      LATERAL VENTRICULAR ENLARGEMENT IN SCHIZOTYPAL PERSONALITY-DISORDER

      Psychiatry research
    32. FRIEDMAN L; JESBERGER JA; SIEVER LJ; THOMPSON P; MOHS R; MELTZER HY
      SMOOTH-PURSUIT PERFORMANCE IN PATIENTS WITH AFFECTIVE-DISORDERS OR SCHIZOPHRENIA AND NORMAL CONTROLS - ANALYSIS WITH SPECIFIC OCULOMOTOR MEASURES, RMS ERROR AND QUALITATIVE RATINGS

      Psychological medicine
    33. GALASKO D; EDLAND SD; MORRIS JC; CLARK C; MOHS R; KOSS E
      THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD).11. CLINICAL MILESTONES IN PATIENTS WITH ALZHEIMERS-DISEASE FOLLOWEDOVER 3 YEARS

      Neurology
    34. LAWLOR BA; RYAN TM; BIERER LM; SCHMEIDLER J; HAROUTUNIAN V; MOHS R; DAVIS KL
      LACK OF ASSOCIATION BETWEEN CLINICAL SYMPTOMS AND POSTMORTEM INDEXES OF BRAIN-SEROTONIN FUNCTION IN ALZHEIMERS-DISEASE

      Biological psychiatry
    35. TARIOT PN; MACK JL; PATTERSON MB; EDLAND SD; WEINER MF; FILLENBAUM G; BLAZINA L; TERI L; RUBIN E; MORTIMER JA; STERN Y; DOODY R; NELSON N; BLASS J; NOLAN K; HEYMAN A; VANBELLE G; BEEKLEY D; DEVANAND DP; KARP H; CLARK C; RABINS P; MOHS R; MELLOW A; SUNDERLAND T; REISBERG B; KLUGER A; GANGULI M; ROSEN J; EVANS D; HENDERSON V; SCHNEIDER L; MORRIS J; LARSON E; RASKIND M
      THE BEHAVIOR RATING-SCALE FOR DEMENTIA OF THE CONSORTIUM TO ESTABLISHA REGISTRY FOR ALZHEIMERS-DISEASE

      The American journal of psychiatry
    36. WELSH KA; WILKINSON W; FILLENBAUM G; HARRELL L; BEEKLY D; EDLAND S; STERN Y; MOHS R
      RACIAL-DIFFERENCES IN NEUROPSYCHOLOGICAL PERFORMANCE IN ALZHEIMERS-DISEASE

      Annals of neurology
    37. ALTSTIEL LD; GREENBERG D; HAROUTUNIAN V; PERL DP; KEDDACHE M; PUROHIT DP; YANG XP; MOHS R; DAVIS KL
      APOLIPOPROTEIN-E ALLELE EPSILON-4 IN AUTOPSY-CONFIRMED ALZHEIMERS-DISEASE AND CEREBROVASCULAR-DISEASE

      Neurobiology of aging
    38. HERRERA J; LEE H; QUINLAN D; VALANCE J; WIELGUS M; ROTARU E; MOHS R; BUCHSBAUM M
      DELAYED WORD RECALL IN AGED SCHIZOPHRENIA

      Biological psychiatry
    39. LI G; SILVERMAN JM; ALTSTIEL L; HAROUTUNIAN H; BIRSTEIN S; MOHS R; DAVIS KL
      APOLIPOPROTEIN EPSILON-4 ALLELE AND FAMILIAL RISK IN ALZHEIMERS-DISEASE

      Biological psychiatry
    40. SIEVER LJ; FRIEDMAN L; MOSKOWITZ J; MITROPOULOU V; KEEFE R; ROITMAN SL; MERHIGE D; TRESTMAN R; SILVERMAN J; MOHS R
      EYE-MOVEMENT IMPAIRMENT AND SCHIZOTYPAL PSYCHOPATHOLOGY

      The American journal of psychiatry
    41. BERKMAN LF; SEEMAN TE; ALBERT M; BLAZER D; KAHN R; MOHS R; FINCH C; SCHNEIDER E; COTMAN C; MCCLEARN G; NESSELROADE J; FEATHERMAN D; GARMEZY N; MCKHANN G; BRIM G; PRAGER D; ROWE J
      HIGH, USUAL AND IMPAIRED FUNCTIONING IN COMMUNITY-DWELLING OLDER MEN AND WOMEN - FINDINGS FROM THE MACARTHUR FOUNDATION RESEARCH NETWORK ONSUCCESSFUL AGING

      Journal of clinical epidemiology
    42. FILLENBAUM G; WOODBURY M; FILLENBAUM G; MOHS R
      DOES THE MINI-MENTAL STATE MEASURE DISTINCT AREAS OF COGNITIVE-FUNCTIONING - A GRADE OF MEMBERSHIP ANALYSIS OF CERAD DATA

      Annals of neurology
    43. WILKINSON W; FILLENBAUM G; WELSH K; MOHS R
      SUBSETS OF MINI-MENTAL STATE ITEMS CAN DISCRIMINATE BETWEEN STAGES OFALZHEIMERS-DISEASE - AN ANALYSIS OF CERAD DATA

      Annals of neurology
    44. LEE HK; HERRERA J; VALANCE J; HERMAN C; QUINLAN D; MOHS R
      TC-99M HMPAO BRAIN SPECT WITH MEMORY ACTIVATION IN ALZHEIMERS-DISEASE

      The Journal of nuclear medicine
    45. GALASKO D; EDLAND S; MORRIS J; CLARK C; MOHS R; KOSS E; THAL LJ
      CLINICAL MILESTONES IN AN ALZHEIMERS-DISEASE (AD) COHORT DURING 2 YEARS OF FOLLOW-UP - THE CERAD EXPERIENCE

      Neurology
    46. MORRIS JC; EDLAND S; CLARK C; GALASKO D; KOSS E; MOHS R; VANBELLE G; FILLENBAUM G; HEYMAN A
      THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD).4. RATES OF COGNITIVE CHANGE IN THE LONGITUDINAL ASSESSMENT OF PROBABLE ALZHEIMERS-DISEASE

      Neurology
    47. SPERANZA A; MOHS R; MILLER A
      CLINICAL AND NEUROENDOCRINE PREDICTORS OF MORTALITY IN ALZHEIMERS-DISEASE

      Biological psychiatry
    48. HERMANN C; KEILP J; LEE H; QUINLAN D; VALANCE J; HERRERA J; MOHS R
      MEMORY ACTIVATION IN ALZHEIMERS-DISEASE WITH TC-99M-HMPAO

      Biological psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 20:21:09